Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) announced that it has initiated a Phase 1 clinical study and has begun dosing healthy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE